Today: 17 June 2026
Browse Category

NASDAQ:ATAI 18 October 2025 - 16 June 2026

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Atai Life Sciences shares surged 18% to close near $6.45 on Oct. 17, 2025, after the FDA granted Breakthrough Therapy status to its experimental depression nasal spray BPL-003. The company raised $130 million in a public offering at $5.48 per share. Analysts issued strong Buy ratings with targets up to $15. ARK Invest disclosed buying about 250,000 shares.
18 October 2025
·

Stock Market Today

  • Dow Hits Record High Driven by Strong Bank and Industrial Stocks; Nasdaq, S&P 500 Slip on Tech Weakness
    June 16, 2026, 7:00 PM EDT. The Dow Jones Industrial Average rose 0.6% to a record 51,999.67, buoyed by strong performances in banking and industrial sectors, with Caterpillar up over 2% and JPMorgan Chase gaining more than 3%. Meanwhile, the S&P 500 and Nasdaq 100 declined by 0.1% and 1.9%, respectively, pressured by weakness in technology stocks. Oil prices fell sharply, with Brent crude dipping below $80 per barrel, easing inflation concerns ahead of the Federal Reserve's policy meeting. SpaceX shares jumped nearly 5% following its Nasdaq debut and acquisition of AI startup Cursor. Investors await the Fed's decision, widely expected to maintain current rates, focusing on inflation outlook and monetary policy guidance.

Latest articles

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

17 June 2026
Aditxt shares plunged 17% to $0.0109 amid nearly 929 million shares traded, as Nasdaq delisting risk and uncertainty over the $150 million Ignite Proteomics spin-off overshadowed HRT Financial’s purchase of 4.25 million shares at $0.016; the stock’s fate hinges on compliance and the Ignite deal’s completion.
Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

17 June 2026
Sadot Group shares plunged 63.1% to $8.67 after a late-session volatility pause as investors weighed a looming June 22 Nasdaq delisting deadline tied to a stockholders’ equity shortfall, a $125.5 million Los Angeles property option paid with 17.71% of its stock, and ongoing liquidity and default risks.
Pfizer trades up with Rigel’s Veppanu deal done

Pfizer trades up with Rigel’s Veppanu deal done

17 June 2026
Pfizer shares edged up 0.15% to $26.04 after Rigel closed a Veppanu licensing deal with Arvinas and Pfizer, triggering a $35 million payment to Pfizer; the deal highlights ongoing investor focus on whether Pfizer’s oncology and obesity pipeline can offset COVID declines and looming patent losses, with analysts split on pipeline potential versus slow growth and patent pressure.
Go toTop